Amylin antagonist peptides and uses therefor
US5580953A · kind A · utility
19Cited by
5References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 1991 |
| Grant date | Dec 3, 1996 |
| Priority date | — |
| Expiry date | Nov 19, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds which inhibit amylin activity are provided. These compounds may be used in the treatment of conditions where it is of benefit to reduce amylin activity, including the treatment of Type 2 diabetes mellitus, impaired glucose tolerance, obesity and insulin resistance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.